RE:Soon catalysts of THTX?There always could be catalysts that the company is working on and that we know nothing about. But of the known catalysts, here is what I can see:
1.) Q1 financial results in early April
2.) AACR presentation on April10th
3.) Start of phase I cancer trial (May?)
4.) Confirmation that the FDA and TH have reached a final NASH trial protocol - uknown timeframe for that
5.) Result of discussions with the EMA over the NASH trial - unknown timeframe and this seemingly has the highest chance of a negative outcome.
6.) AGM in May
7.) Q2 financial results in early July
8.) Safety data on phase I cancer trial in late summer
9.) Start of the phase III NASH trial in late summer
10.) Efficacy data on phase I cancer trial at the end of the year
That is what I could quickly think of - hopefully others will add to this list. I am sure I missed something and I am also sure the company will announce other things along the way that we cannot know about ahead of time.
To me, the easiest route to a higher share price is getting the stock to be treated fairly for its NASH opportunity. Cancer is a real wild card and could turn out to be a very big deal that ultimately leads the company to be acquired by a big pharma company. But it also could be a big flop and the catalysts from it are coming at the backend of the year. The company is looking to hire someone for corporate development/partnerships so it stands to reason there could be some news on that front in the months ahead.
The stock has been chornically undervalued for the last couple of years, mostly because of the inability of the company to convince the market of the fact they are a legit NASH player and despite increasing resources being spent on investor relations (first a consultant and then the hiring of Leah). I a not sure what finally will convince the market the NASH opportunity is real but when that happens, the stock should move considerably higher.
Adonis wrote: Whats the next catalysts for THTX guys?..